Tuberc Respir Dis Search

CLOSE


Tuberc Respir Dis > Volume 62(3); 2007 > Article
Tuberculosis and Respiratory Diseases 2007;62(3):217-222.
DOI: https://doi.org/10.4046/trd.2007.62.3.217    Published online March 1, 2007.
Two Cases of Fatal Hypoxemia after Talc Pleurodesis for Recurrent Malignant Pleural Effusion.
Shin Ae Park, , Han Hee Lee, , Dae Jun Kim, , Byoung Yong Shim, , So Hyang Song, , Chi Hong Kim, , Myeong Im Ahn, , Deog Gon Cho, , Kyu Do Cho, , Hoon Kyo Kim,
1Department of Internal Medicine, The Catholic University or Korea, Suwon, Korea. kimhoonkyo@yahoo.co.kr
2Department of Radiology, The Catholic University or Korea, Suwon, Korea.
3Department of Thoracic Surgery College of Medicine, The Catholic University or Korea, Suwon, Korea.
Abstract
Talc pleurodesis is a safe and effective treatment for a recurrent malignant pleural effusion. However, acute hypoxemia, pulmonary edema or acute respiratory failure can develop in a small number of patients. We report 2 patients who developed fatal hypoxemia after talc pleurodesis which was necessary the control recurrent pleural effusion. The first case was an 18-year old male diagnosed with Ewing's sarcoma with bilateral lung metastases and pleural effusion. The performance status was ECOG (Eastern Cooperative Foncology Group) grade 3. Fever along with hypoxemia and leukocytosis developed 10 hours after the second talc pleurodesis on the right side for an uncontrolled pleural effusion, The patient died from respiratory failure after 13 days. The second case was a 66-year old female diagnosed with non-small cell lung cancer with a bone metastasis. Two weeks after systemic chemotherapy, she complained of dyspnea, and a pleural effusion was observed on the right side. Her performance status was ECOG grade 3. Talc pleurodesis was performed for recurrent pleural effusion, but hypoxemia developed 6 days after pleurodesis and she died from respiratory failure 10 days after pleurodesis. In conclusion, talc pleurodesis should be performed very carefully in patients with a poor performance status, in cases with repeated pleurodesis, bilateral pleural effusion, recent chemotherapy, radiotherapy and when there are parenchymal metastatic lesions present.
Key Words: Pleural effusion, Talc, Pleurodesis, Hypoxemia


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2021 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2community

Close layer
prev next